Windlas Biotech IPO received a decent response across all categories – QIB, NII, and RII. Windlas Biotech Limited raised a total of ₹401.54 Cr crore from this issue, which consists of a fresh issue of ₹165 Cr and an offer for sale ₹336.54 Cr by the promoter and selling shareholders. The issue was subscribed 22.39 times overall.
LinkInTime, the registrar of the issue, is expected to finalize Windlas BiotechIPO Allotment on 11/08/2021. To check your Windlas Biotech IPO Allotment status please follow the instructions shared below.
Windlas BiotechIPO Allotment: Final Subscription Status